Evolving Guidelines: Diagnosis of Diabetes


A recent consensus statement from an expert panel convened by the American Diabetes Association, European Association for the Study of Diabetes, and the International Diabetes Federation, is now recommending the routine use of A1c for the diagnosis of diabetes, citing it’s superiority to the FPG and 2HPG.
In short, the recommendations are:
A1c >6.5% = diabetes
A1c 6.0 – 6.5% = pre-diabetic state (“at risk for diabetes”)
The statement reviews papers in which the A1c was a better predictor of diabetic complications (retinopathy) than the FPG and 2HPG.
The A1c cannot be relied upon in conditions involving rapid changes in red cell turnover, such as hemolytic anemia, malaria, major blood loss, or recent blood transfusion.  Also, since A1c represents chronic glycemic exposure, there are rare clinical instances where the A1c hasn’t “caught up” to the FPG such as rapid onset T1DM or gestational DM.
The ADA has never officially recommended A1c for diabetes diagnosis and has, instead, kept with the FPG and 2HPG for diagnosis.  The anticipation is that the ADA, EASD, and IDF will all make official statements soon supporting its use.

One thought on “Evolving Guidelines: Diagnosis of Diabetes

  1. Since the hemoglobin A1c is not subject to the wide daily fluctuations of other measurements, it would seem to be a more useful tool than the others. But it still needs to be just one of several tools, and doctors and patients should still emphasize diet over medications whenever possible.

    Many different health guidelines have recently been amended to include millions of new BigPharma victims … oh, sorry, I mean patients. Sometimes these guideline changes seem more like marketing tools for drug companies than genuine public health measures.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.